3Kim SJ, Hong YP, Lew WJ, et al. Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis, 1995,76 : 529.
4Leung CC, Li T, Lam TH, et al. Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med , 2004,168:1027-1033.
5Perez-Guzman C, Vargas MH, Torres-Cruz A, et al.Does aging modify pulmonary tuberculosis? A metaanalytical analysis. Chest , 1999,116 :961-967.
6American Thorcic Society/Centers for Disease Control and Prevention /Infections Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med, 2003,167: 603-662.
7Teleman MD, Chee CS, Earnest A, et al.Hepatotoxicity of tuberculosis Chemotherapy under general program conditions in Singapore. Int J Tuber Lung Dis, 2000, 6: 699-705.
8Sharma SK, Balamurugan A, Saha PK, et al.Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med ,2002,166:916-919.
9Huang YS, Chern HD,Su WJ ,et al. Polymorphism of the N-acetyl transferase gene as a susceptibility risk factors for antituberculosis drug-induced hepatitis.Hepatology, 2002,35: 883-889.
10Fernandez-Villar A, Sopena B, Fernandez-Villar J, et al. The influence of risk factors on the severity of antituberculosis drug-induced hepatotoxicity. Int J Tuber Lung Dis, 2004,8:1499-1505.
